Divine 9 personal lubricant has been selected by McGill University’s Division of Cancer Epidemiology for use in their large-scale, double-blind human trial on the ability of a personal lubricant to prevent the transmission of human papillomavirus (HPV). The study is called CATCH, an acronym for Carrageenan-gel Against Transmission of Cervical HPV, and will involve tracking HPV infections in over four hundred female volunteers for a one year period. Divine 9 was the only personal lubricant selected for the trial.
The McGill University research team is led by Dr. Eduardo Franco, Director of the Division of Cancer Epidemiology and is coordinated by Joseph Tota (PhD candidate). Dr. Franco, a renowned expert on the prevention of cervical cancer and HPV-associated diseases, has published over 300 scientific articles and spoken at over 300 conferences worldwide.“The CATCH study is a major initiative to determine if using a carrageenan-based gel can prevent the acquisition and transmission of HPV in a real world setting,” explained Dr. Franco. Simply ahead and have a go at running windows update diagnostic once more. Regardless of the possibility that the troubleshooter says it couldn’t recognize the issue, it’s conceivable that the activities of beginning and halting the administration and getting out the reserve did the trap“I’m extremely encouraged by the results of the laboratory studies by Dr. John Schiller’s team at the National Cancer Institute. If the trial is successful, it would mean that women have another option for protecting themselves against HPV, the causative agent for cervical cancer.”